How Our Knowledge of Neuroinflammatory Pathophysiology Informs Understanding Potential Benefits of Cell Therapies
Time: 11:00 am
day: Day One Track B, AM
Details:
• Discussing mechanistic insights into neuroinflammatory diseases such as multiple sclerosis
• Evaluating which neuroinflammatory patients are most amenable to which cell therapies based on disease understanding
